This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Sloan-Kettering Institute for Cancer Research, Invitrogen Corporation. Active years: 2010-2012.
Company Filing History:
2 out of 518 
1 out of 143 
Years Active: 2010-2012
Title: John Comiskey: Innovator in DNA and RNA Research
Introduction
John Comiskey is a notable inventor based in Carlsbad, California, recognized for his contributions to the field of molecular biology. He holds 2 patents that focus on innovative methods for joining DNA and RNA strands, which have significant implications in genetic research and biotechnology.
Latest Patents
Comiskey's latest patents include groundbreaking methods for covalently joining DNA strands to RNA strands, catalyzed by vaccinia topoisomerase. The first patent outlines a method of tagging the 5' end of an RNA molecule and describes a DNA-RNA molecule that has been joined in vitro using a topoisomerase. The second patent further elaborates on the process of forming a topoisomerase-DNA intermediate and the conditions necessary for ligation, providing a comprehensive approach to isolating and cloning full-length gene sequences using capped mRNA.
Career Highlights
Throughout his career, John Comiskey has worked with prestigious organizations, including the Sloan-Kettering Institute for Cancer Research and Invitrogen Corporation. His work has contributed to advancements in cancer research and genetic engineering, showcasing his commitment to scientific innovation.
Collaborations
Comiskey has collaborated with esteemed colleagues such as Stewart Shuman and JoAnn Sekiguchi, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
John Comiskey's innovative work in DNA and RNA research exemplifies the importance of scientific advancements in biotechnology. His patents and collaborations reflect a dedication to improving genetic research methodologies, making significant contributions to the field.